백진호 교수
#위암#대장암#식도암#위장관기질종양#복막중피종#간암#췌담도암#호스피스 완화의료
|
학력
1996년 경북대학교 의과대학 의학과 졸업 (의학학사)
1999년 경북대학교 의과대학 대학원 석사
2006년 경북대학교 의과대학 대학원 박사 (내과학)
1999년 경북대학교 의과대학 대학원 석사
2006년 경북대학교 의과대학 대학원 박사 (내과학)
경력
1997년3월-2001년2월: 경북대학교병원 내과 전공의
2004년5월-2006년2월: 경북대학교병원 혈액종양내과 전임의
2006년3월-2007년2월: 경주 동국대학교병원 혈액종양내과 조교수
2007년3월-2012년9월: 울산대학교병원 혈액종양내과 조교수
2012년10월-2018년8월: 울산대학교병원 혈액종양내과 부교수
2018년9월-2019년 2월: 울산대학교병원 혈액종양내과 교수
2019년 2월 - 2020년 2월 : 경북대학교병원 혈액종양내과 임상교수
2020년 3월 - 현재 : 경북대학교병원 혈액종양내과 교수
2004년5월-2006년2월: 경북대학교병원 혈액종양내과 전임의
2006년3월-2007년2월: 경주 동국대학교병원 혈액종양내과 조교수
2007년3월-2012년9월: 울산대학교병원 혈액종양내과 조교수
2012년10월-2018년8월: 울산대학교병원 혈액종양내과 부교수
2018년9월-2019년 2월: 울산대학교병원 혈액종양내과 교수
2019년 2월 - 2020년 2월 : 경북대학교병원 혈액종양내과 임상교수
2020년 3월 - 현재 : 경북대학교병원 혈액종양내과 교수
논문
1. Kim JW, Kim JG, Kang BW, Chung IJ, Hong YS, Kim TY, Song HS, Lee KH, Zang DY, Ko YH, Song EK, Baek JH, Koo DH, Oh SY, Cho H, Lee KW. Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer. Cancer Res Treat. 2019 Jan;51(1):223-239. doi: 10.4143/crt.2018.073. Epub 2018 Oct 19.
2. Jung M, Ryu MH, Oh DY, Kang M, Zang DY, Hwang IG, Lee KW, Kim KH, Shim BY, Song EK, Sym SJ, Han HS, Park YL, Kim JS, Lee HW, Lee MH, Koo DH, Song HS, Lee N, Yang SH, Choi DR, Hong YS, Lee KE, Maeng CH, Baek JH, Kim S, Kim YH, Rha SY, Cho JY, Kang YK. Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG). Gastric Cancer. 2018 Sep;21(5):819-830. doi: 10.1007/s10120-018-0806-1. Epub 2018 Feb 9
3. Kim JY, Do YR, Song HS, Cho YY, Ryoo HM, Bae SH, Kim JG, Chae YS, Kang BW, Baek JH, Kim MK, Lee KH, Park K. Multicenter Phase II Clinical Trial of Genexol-PM® with Gemcitabine in Advanced Biliary Tract Cancer. Anticancer Res. 2017 Mar;37(3):1467-1473.
4. Seol YM, Kim HJ, Choi YJ, Lee EM, Kim YS, Oh SY, Koh SJ, Baek JH, Lee WS, Joo YD, Lee HG, Yun EY, Chung JS. Transdermal granisetron versus palonosetron for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: a multicenter, randomized, open-label, cross-over, active-controlled, and phase IV study. Support Care Cancer. 2016 Feb;24(2):945-52.
5. Kim JY, Ryoo HM, Bae SH, Kang BW, Chae YS, Yoon S, Baek JH, Kim MK, Lee KH, Lee SA, Song HS, Kim JG. Multi-center Randomized Phase II Study of Weekly Docetaxel Versus Weekly Docetaxel-plus-Oxaliplatin as a Second-line Chemotherapy for Patients with Advanced Gastric Cancer. Anticancer Res. 2015 Jun;35(6):3531-6.
6. Jo JC, Baek JH, Koh SJ, Kim H, Min YJ, Lee BU, Kim BG, Jeong ID, Cho HR, Kim GY. Adjuvant chemotherapy for elderly patients (aged 70 or older) with gastric cancer after a gastrectomy with D2 dissection: A single center experience in Korea. Asia Pac J Clin Oncol. 2015 Apr 9. doi: 10.1111/ajco.12349. [Epub ahead of print]
7. Baek JH, Sun JM, Min YJ, Cho EK, Cho BC, Kim JH, Ahn MJ, Park K. Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer except both exon 19 deletion and exon 21 L858R: a retrospective analysis in Korea. Lung Cancer. 2015 Feb;87(2):148-54. doi: 10.1016/j.lungcan.2014.11.013. Epub 2014 Nov 29.
8. Shin SH, Lee HS, Kim YS, Choi YJ, Kim SH, Kwon HC, Oh SY, Kang JH, Sohn CH, Lee SM, Baek JH, Min YJ, Kim C, Chung JS. Clinical Usefulness of Hydromorphone-OROS in Improving Sleep Disturbances in Korean Cancer Patients: A Multicenter, Prospective, Open-Label Study. Cancer Res Treat. 2014 Oct;46(4):331-8. doi: 10.4143/crt.2013.130. Epub 2014 Jul 21.
9. Baek SK, Shin HW, Choi YJ, Zang DY, Cho DY, Ryoo HM, Baek JH, Kim SY, Song HS. Noninterventional observational study using high-dose controlled-release oxycodone (CR oxycodone) for cancer pain management in outpatient clinics. Pain Med. 2013 Dec;14(12):1866-72. doi: 10.1111/pme.12228. Epub 2013 Sep 6.
10. Choi YH, Oh SC, Kim JS, Nam SH, Kim BS, Cho SH, Chung IJ, Song EK, Yim CY, Baek JH, Jeung HC, Hong YS, Yang SH, Kang HJ A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02. Cancer Chemother Pharmacol. 2012 Nov;70(5):665-72. doi: 10.1007/s00280-012-1956-1. Epub 2012 Aug 25.
11. Park LC, Lee HS, Shin SH, Park SJ, Park MI, Oh SY, Kwon HC, Baek JH, Choi YJ, Kang MJ, Kim YS. Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer. World J Gastroenterol. 2012 Mar 14;18(10):1104-9. doi: 10.3748/wjg.v18.i10.1104.
12. Baek JH, Moon CH, Cha SJ, Lee HS, Noh EK, Kim H, Won JH, Min YJ. Arsenic trioxide induces depolymerization of microtubules in an acute promyelocytic leukemia cell line. Korean J Hematol. 2012 Jun;47(2):105-12. Epub 2012 Jun 26.
13. Baek JH, Kim H, Ahn JJ, Jegal Y, Seo KW, Ra SW, Park CR, Jung JP, Kim JW, Lee YJ, Cha HJ, Kwon WJ, Noh YJ, Oh S, Park JH, Min YJ. Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer. Lung Cancer. 2012 Jun;76(3):368-72. Epub 2011 Dec 20.
14. Choi BS, Baek JH, Shin YM, Kim JH, Kim HW, Lee SJ, Cha HJ. Follicular dendritic cell sarcoma: a case report and review of the literature. Cancer Res Treat. 2010 Jun;42(2):121-4. Epub 2010 Jun 30.
15. Kim JY, Do YR, Park KU, Kim JG, Chae YS, Kim MK, Lee KH, Ryoo HM, Bae SH, Baek JH, Song HS. Multicenter phase II trial of S-1, paclitaxel and cisplatin triplet combination chemotherapy in patients with advanced gastric cancer. Cancer Chemother Pharmacol. 2011 Mar;67(3):527-32. Epub 2010 May 12.
16. Moon JH, Kim SN, Kang BW, Chae YS, Kim JG, Baek JH, Park JH, Song MK, Chung JS, Won JH, Lee SM, Joo YD, Kim YK, Kim HJ, Jo DY, Sohn SK. Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment. Ann Hematol. 2010 Jul;89(7):681-9. Epub 2010 Mar 17.
17. Kim JY, Do YR, Park KU, Kim MK, Lee KH, Bae SH, Ryoo HM, Baek JH, Song HS. A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer. Cancer Chemother Pharmacol. 2010 May;66(1):31-6. Epub 2009 Sep 18
18. Lee JL, Kang YK, Kang HJ, Lee KH, Zang DY, Ryoo BY, Kim JG, Park SR, Kang WK, Shin DB, Ryu MH, Chang HM, Kim TW, Baek JH, Min YJ. A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer. Br J Cancer. 2008 Aug 19;99(4):584-90. Epub 2008 Jul 29.
19. Baek JH, Sohn SK, Kim DH, Kim JG, Yang DH, Kim YK, Lee JJ, Kim HJ. Pilot Remission Induction Therapy with Idarubicin, plus an Intensified Dose of Ara-C and Priming with Granulocyte Colony-Stimulating Factor for Acute Myeloid Leukemia. Acta Haematol. 2007;28;117(2):109-114
20. Kim JG, Sohn SK, Chae YS, Song HS, Kwon KY, Do YR, Kim MK, Lee KH, Hyun MS, Ryoo HM, Bae SH, Park KU, Lee WS, Baek JH, Chung HY, Yu W. Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group. Br J Cancer. 2008 Feb 12;98(3):542-6
21. Bae SH, Ryoo HM, Do YR, Song HS, Kwon KY, Kim MK, Lee KH, Hyun MS, Lee WS, Hur IK, Baek JH, Park KU. A phase II study of biweekly irinotecan and cisplatin for patients with extensive stage disease small cell lung cancer. Lung Cancer. 2008 Jan;59(1):76-80
22. Kim JG, Sohn SK, Song HS, Kwon KY, Do YR, Lee KH, Hyun MS, Ryoo HM, Bae SH, Park KU, Baek JH, Lee WS, Chung JS, Cho GJ, Sohn CH, Jang JS, Chung HY, Yu W. Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer. Cancer Chemother Pharmacol. 2007 Nov;60(6):863-9
23. Baek JH, Sohn SK, Kim DH, Kim JG, Yang DH, Kim YK, Lee JJ, Kim HJ. Pilot Remission Induction Therapy with Idarubicin, plus an Intensified Dose of Ara-C and Priming with Granulocyte Colony-Stimulating Factor for Acute Myeloid Leukemia. Acta Haematol. 2007;28;117(2):109-114
24. Baek JH, Kim JG, Jeon SB, Chae YS, Kim DH, Sohn SK, Lee KB, Choi YJ, Shin HJ, Chung JS, Cho GJ, Jung HY, Yu W. Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer. Br J Cancer. 2006 May 22;94(10):1407-11.
25. Baek JH, Kim JG, Sohn SK, Kim DH, Lee KB, Song HS, Kwon KY, Do YR, Ryoo HM, Bae SH, Park KU, Kim MK, Lee KH, Hyun MS, Chunh HY, Yu W. Biweekly irinotecan and cisplatin as second-line chemotherapy in pretreated patients with advanced gastric cancer: a Multicenter Phase II study. J Korean Med Sci. 2005; 20:966-970.
26. Baek JH, Sohn SK, Kim DH, Kim JG, Lee HW, Park SP, Lee KB. Wernicke's encephalopathy after allogeneic stem cell transplantation. Bone Marrow Transplant 2005; 35: 829-830.
2. Jung M, Ryu MH, Oh DY, Kang M, Zang DY, Hwang IG, Lee KW, Kim KH, Shim BY, Song EK, Sym SJ, Han HS, Park YL, Kim JS, Lee HW, Lee MH, Koo DH, Song HS, Lee N, Yang SH, Choi DR, Hong YS, Lee KE, Maeng CH, Baek JH, Kim S, Kim YH, Rha SY, Cho JY, Kang YK. Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG). Gastric Cancer. 2018 Sep;21(5):819-830. doi: 10.1007/s10120-018-0806-1. Epub 2018 Feb 9
3. Kim JY, Do YR, Song HS, Cho YY, Ryoo HM, Bae SH, Kim JG, Chae YS, Kang BW, Baek JH, Kim MK, Lee KH, Park K. Multicenter Phase II Clinical Trial of Genexol-PM® with Gemcitabine in Advanced Biliary Tract Cancer. Anticancer Res. 2017 Mar;37(3):1467-1473.
4. Seol YM, Kim HJ, Choi YJ, Lee EM, Kim YS, Oh SY, Koh SJ, Baek JH, Lee WS, Joo YD, Lee HG, Yun EY, Chung JS. Transdermal granisetron versus palonosetron for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: a multicenter, randomized, open-label, cross-over, active-controlled, and phase IV study. Support Care Cancer. 2016 Feb;24(2):945-52.
5. Kim JY, Ryoo HM, Bae SH, Kang BW, Chae YS, Yoon S, Baek JH, Kim MK, Lee KH, Lee SA, Song HS, Kim JG. Multi-center Randomized Phase II Study of Weekly Docetaxel Versus Weekly Docetaxel-plus-Oxaliplatin as a Second-line Chemotherapy for Patients with Advanced Gastric Cancer. Anticancer Res. 2015 Jun;35(6):3531-6.
6. Jo JC, Baek JH, Koh SJ, Kim H, Min YJ, Lee BU, Kim BG, Jeong ID, Cho HR, Kim GY. Adjuvant chemotherapy for elderly patients (aged 70 or older) with gastric cancer after a gastrectomy with D2 dissection: A single center experience in Korea. Asia Pac J Clin Oncol. 2015 Apr 9. doi: 10.1111/ajco.12349. [Epub ahead of print]
7. Baek JH, Sun JM, Min YJ, Cho EK, Cho BC, Kim JH, Ahn MJ, Park K. Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer except both exon 19 deletion and exon 21 L858R: a retrospective analysis in Korea. Lung Cancer. 2015 Feb;87(2):148-54. doi: 10.1016/j.lungcan.2014.11.013. Epub 2014 Nov 29.
8. Shin SH, Lee HS, Kim YS, Choi YJ, Kim SH, Kwon HC, Oh SY, Kang JH, Sohn CH, Lee SM, Baek JH, Min YJ, Kim C, Chung JS. Clinical Usefulness of Hydromorphone-OROS in Improving Sleep Disturbances in Korean Cancer Patients: A Multicenter, Prospective, Open-Label Study. Cancer Res Treat. 2014 Oct;46(4):331-8. doi: 10.4143/crt.2013.130. Epub 2014 Jul 21.
9. Baek SK, Shin HW, Choi YJ, Zang DY, Cho DY, Ryoo HM, Baek JH, Kim SY, Song HS. Noninterventional observational study using high-dose controlled-release oxycodone (CR oxycodone) for cancer pain management in outpatient clinics. Pain Med. 2013 Dec;14(12):1866-72. doi: 10.1111/pme.12228. Epub 2013 Sep 6.
10. Choi YH, Oh SC, Kim JS, Nam SH, Kim BS, Cho SH, Chung IJ, Song EK, Yim CY, Baek JH, Jeung HC, Hong YS, Yang SH, Kang HJ A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02. Cancer Chemother Pharmacol. 2012 Nov;70(5):665-72. doi: 10.1007/s00280-012-1956-1. Epub 2012 Aug 25.
11. Park LC, Lee HS, Shin SH, Park SJ, Park MI, Oh SY, Kwon HC, Baek JH, Choi YJ, Kang MJ, Kim YS. Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer. World J Gastroenterol. 2012 Mar 14;18(10):1104-9. doi: 10.3748/wjg.v18.i10.1104.
12. Baek JH, Moon CH, Cha SJ, Lee HS, Noh EK, Kim H, Won JH, Min YJ. Arsenic trioxide induces depolymerization of microtubules in an acute promyelocytic leukemia cell line. Korean J Hematol. 2012 Jun;47(2):105-12. Epub 2012 Jun 26.
13. Baek JH, Kim H, Ahn JJ, Jegal Y, Seo KW, Ra SW, Park CR, Jung JP, Kim JW, Lee YJ, Cha HJ, Kwon WJ, Noh YJ, Oh S, Park JH, Min YJ. Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer. Lung Cancer. 2012 Jun;76(3):368-72. Epub 2011 Dec 20.
14. Choi BS, Baek JH, Shin YM, Kim JH, Kim HW, Lee SJ, Cha HJ. Follicular dendritic cell sarcoma: a case report and review of the literature. Cancer Res Treat. 2010 Jun;42(2):121-4. Epub 2010 Jun 30.
15. Kim JY, Do YR, Park KU, Kim JG, Chae YS, Kim MK, Lee KH, Ryoo HM, Bae SH, Baek JH, Song HS. Multicenter phase II trial of S-1, paclitaxel and cisplatin triplet combination chemotherapy in patients with advanced gastric cancer. Cancer Chemother Pharmacol. 2011 Mar;67(3):527-32. Epub 2010 May 12.
16. Moon JH, Kim SN, Kang BW, Chae YS, Kim JG, Baek JH, Park JH, Song MK, Chung JS, Won JH, Lee SM, Joo YD, Kim YK, Kim HJ, Jo DY, Sohn SK. Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment. Ann Hematol. 2010 Jul;89(7):681-9. Epub 2010 Mar 17.
17. Kim JY, Do YR, Park KU, Kim MK, Lee KH, Bae SH, Ryoo HM, Baek JH, Song HS. A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer. Cancer Chemother Pharmacol. 2010 May;66(1):31-6. Epub 2009 Sep 18
18. Lee JL, Kang YK, Kang HJ, Lee KH, Zang DY, Ryoo BY, Kim JG, Park SR, Kang WK, Shin DB, Ryu MH, Chang HM, Kim TW, Baek JH, Min YJ. A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer. Br J Cancer. 2008 Aug 19;99(4):584-90. Epub 2008 Jul 29.
19. Baek JH, Sohn SK, Kim DH, Kim JG, Yang DH, Kim YK, Lee JJ, Kim HJ. Pilot Remission Induction Therapy with Idarubicin, plus an Intensified Dose of Ara-C and Priming with Granulocyte Colony-Stimulating Factor for Acute Myeloid Leukemia. Acta Haematol. 2007;28;117(2):109-114
20. Kim JG, Sohn SK, Chae YS, Song HS, Kwon KY, Do YR, Kim MK, Lee KH, Hyun MS, Ryoo HM, Bae SH, Park KU, Lee WS, Baek JH, Chung HY, Yu W. Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group. Br J Cancer. 2008 Feb 12;98(3):542-6
21. Bae SH, Ryoo HM, Do YR, Song HS, Kwon KY, Kim MK, Lee KH, Hyun MS, Lee WS, Hur IK, Baek JH, Park KU. A phase II study of biweekly irinotecan and cisplatin for patients with extensive stage disease small cell lung cancer. Lung Cancer. 2008 Jan;59(1):76-80
22. Kim JG, Sohn SK, Song HS, Kwon KY, Do YR, Lee KH, Hyun MS, Ryoo HM, Bae SH, Park KU, Baek JH, Lee WS, Chung JS, Cho GJ, Sohn CH, Jang JS, Chung HY, Yu W. Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer. Cancer Chemother Pharmacol. 2007 Nov;60(6):863-9
23. Baek JH, Sohn SK, Kim DH, Kim JG, Yang DH, Kim YK, Lee JJ, Kim HJ. Pilot Remission Induction Therapy with Idarubicin, plus an Intensified Dose of Ara-C and Priming with Granulocyte Colony-Stimulating Factor for Acute Myeloid Leukemia. Acta Haematol. 2007;28;117(2):109-114
24. Baek JH, Kim JG, Jeon SB, Chae YS, Kim DH, Sohn SK, Lee KB, Choi YJ, Shin HJ, Chung JS, Cho GJ, Jung HY, Yu W. Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer. Br J Cancer. 2006 May 22;94(10):1407-11.
25. Baek JH, Kim JG, Sohn SK, Kim DH, Lee KB, Song HS, Kwon KY, Do YR, Ryoo HM, Bae SH, Park KU, Kim MK, Lee KH, Hyun MS, Chunh HY, Yu W. Biweekly irinotecan and cisplatin as second-line chemotherapy in pretreated patients with advanced gastric cancer: a Multicenter Phase II study. J Korean Med Sci. 2005; 20:966-970.
26. Baek JH, Sohn SK, Kim DH, Kim JG, Lee HW, Park SP, Lee KB. Wernicke's encephalopathy after allogeneic stem cell transplantation. Bone Marrow Transplant 2005; 35: 829-830.
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.